Catalyst Said to Take Therapure Public, Weighs Casino IPO

  • Private equity firm to raise more than $75 million in IPO
  • Mississauga-based Therapure focuses on biopharmaceuticals

Catalyst Capital Group Inc., a Canadian private equity firm, is seeking to raise at least C$100 million ($75 million) in an initial public offering of Therapure Biopharma Inc., according to people familiar with the sale.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.